Corindus Vascular Robotics, a company based in Waltham, MA, won FDA clearance to introduce its CorPath GRX robotic angiography system. The new generation of the CorPath system is intended to make robotically-assisted angioplasties even more precise, make operation faster for shorter procedure times, and allow for more patients to be treated with it.
The firm’s Active Guide Management technology controls the guide catheter and accompanying stent or balloon within a millimeter accuracy. An intuitive interface and comfortable seating help the physician speed up delivery and placement of the instruments. The actual robotic unit that stands by the patient has been redesigned and includes a touchscreen display that shows relevant information during procedures.
The device was just unveiled at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 in Washington, D.C.
Product page: CorPath GRX…